Xuerong Bio continues trading halt amid control change plans
Shanghai Xuerong Bio-Technology (SZSE:300511) announced an extension of its trading suspension, effective March 10, 2025, as negotiations continue regarding a potential change in control. The move follows an initial suspension on March 6, prompted by a notification from controlling shareholder Yang Yongping concerning the planned transfer of 25.33% of the company's voting rights to a private technology services firm, subject to regulatory approvals. The company expects the suspension to last no more than three trading days. Xuerong Bio assures investors it will disclose significant developments and promptly apply for resumption of trading once matters are finalized.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
News Alerts
Get instant email alerts when Shanghai Xuerong Bio-Technology publishes news
Free account required • Unsubscribe anytime